The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA

Antiviral therapy (AVT) is the mainstay of hepatitis B virus (HBV) management. We investigated whether AVT improves the outcomes of HBV‐related decompensated cirrhosis and undetectable HBV‐DNA.

[1]  G. D’Amico,et al.  TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. , 2021, Journal of hepatology.

[2]  K. Matsuura,et al.  Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation. , 2021, Journal of hepatology.

[3]  R. Gani,et al.  Managing liver cirrhotic complications: Overview of esophageal and gastric varices , 2020, Clinical and molecular hepatology.

[4]  Min Zheng,et al.  Hepatitis B virus persistence and reactivation , 2020, BMJ.

[5]  M. Yuen,et al.  Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  J. Jang.  KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications , 2020, Clinical and molecular hepatology.

[7]  M. Buti,et al.  Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference , 2019, Hepatology.

[8]  K. Suh,et al.  Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis. , 2019, Oncology letters.

[9]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[10]  J. Bruix,et al.  Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. , 2018, European journal of radiology.

[11]  J. Zucman‐Rossi,et al.  Mechanisms of HBV-induced hepatocellular carcinoma. , 2016, Journal of hepatology.

[12]  M. Yuen,et al.  Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  J. Zucman‐Rossi,et al.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. , 2015, Gastroenterology.

[14]  Jessica Zucman-Rossi,et al.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.

[15]  V. Wong,et al.  Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis , 2013, Hepatology.

[16]  Yoshiyuki Suzuki,et al.  Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection , 2013, Hepatology.

[17]  Y. Liaw,et al.  Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. , 2012, Journal of hepatology.

[18]  H. Yim,et al.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B , 2012, Clinical and molecular hepatology.

[19]  T. Therneau,et al.  Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. , 2009, Gastroenterology.

[20]  H. Kumada,et al.  Correlation between serum hepatitis B virus core‐related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients , 2009, Journal of medical virology.

[21]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[22]  C. Chu,et al.  Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study , 2007, Hepatology international.

[23]  C. Chu,et al.  Hepatitis B virus-related cirrhosis: natural history and treatment. , 2006, Seminars in liver disease.

[24]  E. Christensen,et al.  Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients , 2002, American Journal of Gastroenterology.

[25]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[26]  A. B. Sukhomlinov,et al.  [Liver cirrhosis]. , 1989, Fel'dsher i akusherka.